Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Madrigal Pharmaceuticals Enters into Agreement with CSPC for Oral GLP-1 Agonist
Thursday, July 31, 2025Madrigal Pharmaceuticals has entered into an exclusive global licensing agreement with CSPC Pharmaceutical Group for SYH a preclinical oral small molecule GLP receptor agonist derived from orforglipron
Bio Usawa Biotechnology and Sartorius Partner to Boost Biopharmaceutical Manufacturing in Africa
Wednesday, July 30, 2025Bio Usawa Biotechnology has formed a strategic partnership with Sartorius Stedim Biotech to advance the continents biopharmaceutical manufacturing capabilities
Alamar Biosciences and DZNE Collaborate on Proteomic Profiling in the Rhineland
Wednesday, July 30, 2025Alamar Biosciences has announced a partnership with the German Center for Neurodegenerative Diseases DZNE to support largescale proteomic profiling as part of the Rhineland a major populationbased ageing initiative
Boehringer Ingelheim and Re-Vana Therapeutics Partners to Advance Long-Acting Eye Disease Treatments
Tuesday, July 29, 2025Boehringer Ingelheim has entered a strategic collaboration and licence agreement with ReVana Therapeutics a US and UKbased company specialising in ocular therapeutics and drug delivery technologies
Apellis Receives Approval for EMPAVELI® (C3 Inhibitor) to Treat Rare Kidney Diseases
Tuesday, July 29, 2025Apellis Pharmaceuticals has received approval from the US Food and Drug Administration FDA for EMPAVELI pegcetacoplan as the first treatment for C glomerulopathy CG and primary immune complex membranoproliferative
Antengene’s XPOVIO® Approved for Second-Line Treatment of Multiple Myeloma
Tuesday, July 29, 2025Antengene Corporation has announced that the China National Medical Products Administration NMPA has approved XPOVIO selinexor for the treatment of adult patients with multiple myeloma MM who have received at least one prior therapy
Hengrui Pharma Enters into Agreement with GSK to Develop Up to 12 Innovative Medicines
Monday, July 28, 2025Hengrui Pharma has entered into a strategic collaboration with GSK to jointly develop up to innovative medicines targeting respiratory diseases immunology and inflammation RII and oncology
Ono Pharmaceutical Receives Approval for Opdivo® and Yervoy® Combination to Treat Advanced Liver Cancer
Monday, July 28, 2025Ono Pharmaceutical has announced that it has received approval from the Taiwan Food and Drug Administration TFDA for the combination use of Opdivo nivolumab and Yervoy ipilimumab
Pfizer Enters into Agreement with 3SBio for Innovative Cancer Treatment
Friday, July 25, 2025Pfizer has completed a global licensing agreement with SBio excluding China to develop manufacture and commercialise SSGJ a bispecific antibody targeting PD and VEGF
Candel Therapeutics Secures EMA Orphan Designation for Pancreatic Cancer Therapy
Friday, July 25, 2025Candel Therapeutics has received Orphan Designation from the European Medicines Agency EMA for its lead investigational immunotherapy candidate CAN for the treatment of pancreatic cancer
